AstraZeneca Free Cash Flow 2010-2024 | AZN

AstraZeneca free cash flow for the twelve months ending September 30, 2024 was , a year-over-year.

  • AstraZeneca annual free cash flow for 2023 was $9.116B, a 1.3% increase from 2022.
  • AstraZeneca annual free cash flow for 2022 was $8.999B, a 84.22% increase from 2021.
  • AstraZeneca annual free cash flow for 2021 was $4.885B, a 23.86% increase from 2020.

AstraZeneca Free Cash Flow 2010-2024 | AZN

  • AstraZeneca annual free cash flow for 2023 was $9.116B, a 1.3% increase from 2022.
  • AstraZeneca annual free cash flow for 2022 was $8.999B, a 84.22% increase from 2021.
  • AstraZeneca annual free cash flow for 2021 was $4.885B, a 23.86% increase from 2020.
Related Stocks
Company NameMarket
Cap
Eli Lilly (LLY)$753.9B
Novo Nordisk (NVO)$393.3B
Johnson & Johnson (JNJ)$350.5B
AbbVie (ABBV)$316.7B
Merck (MRK)$252.6B
Novartis AG (NVS)$201.1B
Pfizer (PFE)$150.5B
Sanofi (SNY)$122.9B
Bayer (BAYRY)$19.1B
Innoviva (INVA)$1.1B